WebApr 13, 2024 · About Bio-Techne. Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug ... WebApr 20, 2016 · Bio-Techne. Research & Development · Minnesota, United States · 2,700 Employees . Founded in 1981, Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for …
BIO-TECHNE Corp (TECH) Stock Price & News - Google …
WebBio-Techne Corp (TECH) 71.95 -0.11 ( -0.15%) USD NASDAQ Mar 30, 16:00 71.95 0.00 (0.00%) After-Hours: 20:00 Switch to: Reports Actions Performance Key Stats Financials Estimates News Events Y-Rating Valuation More Price Chart Price Returns View Full Chart Key Stats View All Stats Risk Show Comparables Show Benchmark 3Y 5Y 10Y 15Y all WebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … how to store potatoes properly long term
BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, …
WebApr 12, 2024 · MINNEAPOLIS, April 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 3, 2024, at 8:00 a.m. CDT to review third quarter 2024 financial results. Access to the discussion may be obtained as follows: WebBio-Techne is changing the limits of healthcare Bio-Techne empowers customers to discover, develop and deliver life changing therapies and diagnostics. We believe in an EPIC culture focused on Empowerment, Passion, Innovation and Collaboration and the value of a diverse employee population. WebApr 14, 2024 · The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.15 and a current ratio of 4.40. Bio-Techne Co. has a fifty-two week low of $68.00 and a fifty-two … reade hall crochet club